Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease in which cytokines play an important role. The aim of the present study was to evaluate the −590 IL-4 promoter polymorphism in patients with RA and its association with disease activity and severity. We enrolled 94 patients with RA diagnosed according to the criteria of the American College of Rheumatology. Polymerase chain reaction amplification was used for analysis of the polymorphism at position −590 of the promoter of the IL-4 gene. The distribution of IL-4 genotypes in RA patients did not differ from control subjects. Nevertheless, the active form of RA was more frequently diagnosed in patients with T allele (genotypes CT and TT) as compared with homozygous CC patients. Moreover, in carriers of the T allele, parameters of disease activity (DAS 28 score, ESR, number of swollen and tender joints) were significantly increased. We suggest that the IL-4 −590 promoter polymorphism may be a genetic risk factor for RA severity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
John S, Myerscough A, Marlow A, Hajeer A, Silman A, Ollier W, Worthington J (1998) Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity. Ann Rheum Dis 57:361–365
Ared WP, Dayer JM (1990) Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arth Rheum 33:305–315
Li B,Tournier C, Davis RJ, Flavell RA (1999) Regulation of Il-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J 18:420–432
Wenner CA, Szabo SJ, Murphy KM (1997) Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J Immunol 158:765–773
Castro A, Sengupta TK, Ruiz DC, Yang E, Ivashkiv LB (1999) IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells. J Immunol 162:1261–1269
Vannier E, Miller LC, Dinarello CA (1992) Coordinated anti-inflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 89:4076–4080
Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L (1995) Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25:74–78
Song Z,Casolaro V, Chen R, Georas SN, Monos D, Ono SJ (1996) Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 156:1131–1136
Mout R, Willemze R, Landegent JE (1991) Repeat polymorphisms in the interleukin-4 gene. Nucleic Acid Res 19:3763
Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazieres B (1999) Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthr Rheum 42:1093–1100
Genevay S, Di Giovine FS, Perneger TV, Silvestri T, Stingelin S, Duff G, Guerne PA (2002) Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthr Rheum 47:303–309
Prevoo ML, van ’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthr Rheum 38:44–48
Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in Rheumatoid Arthritis Clinical Trials. Arthr Rheum 36:729–740
Kanemitsu S, Takabayashi A, Sasaki Y, Kuromaru R, Ihara K, Kaku Y, Sakai K, Hara T (1999) Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthr Rheum 42:1298–1300
Maksymowych WP, Suarez-Almazor ME, Buenviaje H, Cooper BL, Degeus C, Thompson M, Russell AS (2002) HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J Rheumatol 29:2319–2326
Noguchi E, Shibasaki M, Arinami T, Takeda K, Yokouchi Y, Kawashima T, Yanagi H, Matsui A, Hamaguchi H (1998) Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy 28:449–453
Li-Weber M, Laur O, Davydov IV, Hu C, Salgame P, Krammer PH (1997) What controls tissue-specific expression of the Il-4 gene? Immunobiology 198:170–178
Cantrell D (1996) T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14:259–274
Kawashima T, Noguchi E, Arinami T, Yamakawa-Kobayashi K, Nakagawa H, Otsuka F, Hamaguchi H (1998) Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 35:502–504
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pawlik, A., Wrzesniewska, J., Florczak, M. et al. The −590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatol Int 26, 48–51 (2005). https://doi.org/10.1007/s00296-004-0539-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-004-0539-9